Bilcare Limited has informed the exchange about the outcome of Board Meeting and approval of Unaudited Financial Results For The Quarter And Nine Months Ended December 31, 2025.
BI · price
▲ positive · ▼ negative · ● neutral filings · teal = economic event · numbered = multiple that day (click to pick). Times IST.
Awaiting price reaction for this filing.
Bilcare Limited's Board approved unaudited standalone and consolidated financial results for Q3 FY26 and 9M FY26. On a standalone basis, total income for Q3 was Rs. 7.27 crores with a net profit of Rs. 2.71 crores (vs Rs. 1.04 crores in Q2 FY26), and 9M net profit improved sharply to Rs. 3.99 crores from Rs. 1.46 crores a year ago. However, standalone revenue from operations dropped sharply to Rs. 1.73 crores in Q3 FY26 from Rs. 5.54 crores in Q3 FY25. On a consolidated basis, the company reported a net loss of Rs. 12.81 crores in Q3 (improved from Rs. 23.32 crores loss in Q2) and Rs. 41.92 crores loss for 9M FY26 (vs Rs. 61.20 crores loss in 9M FY25). The auditor (Patki & Soman) issued a qualified review report flagging CSIR loan penal interest of Rs. 14.42 crores that should have been a provision rather than a contingent liability, and that the defaulted CSIR loan should be reclassified as current borrowing. An emphasis of matter paragraph was also added citing material going-concern uncertainty given past operating losses.
Mixed signals for shareholders — standalone profitability is improving with significant 9M PAT growth, but consolidated entity continues in losses and revenue is declining. The auditor's qualified report, going-concern flag, ongoing SFIO investigation, and CSIR loan default raise meaningful concerns about financial health and may weigh on the stock.